Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 8/20 | 0.67 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.67 |
| ▸ | SLC1A2 | P43004 | 3/20 | 0.61 |
| ▸ | SLC1A1 | P43005 | 3/20 | 0.61 |
| ▸ | SLC1A3 | P43003 | 2/20 | 0.61 |
| ▸ | GRIK1 | P39086 | 3/20 | 0.55 |
| ▸ | GRIK2 | Q13002 | 3/20 | 0.55 |
| ▸ | CA1 | P00915 | 4/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.46 |
| ▸ | HTR2A | P28223 | 1/20 | 0.46 |
| ▸ | HTR2C | P28335 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | HRH1 | P35367 | 1/20 | 0.46 |
| ▸ | DRD3 | P35462 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3128633 | 0.98 | CA2 (0.64) | CA2MAPK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL2230971 | 0.96 | CA2 (0.62) | CA2MAPK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL64421 | 0.94 | GRIK1 (0.62) | CA2MAPK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL1134730 | 0.94 | GRIK1 (0.62) | CA2MAPK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL121781 | 0.94 | GRIK1 (0.62) | CA2MAPK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL9188141 | 0.94 | GRIK1 (0.62) | CA2MAPK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL20918220 | 0.94 | GRIK1 (0.62) | CA2MAPK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL160551 | 0.94 | GRIK1 (0.62) | CA2MAPK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL6508633 | 0.94 | GRIK1 (0.62) | CA2MAPK1SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL5493649 | 0.94 | GRIK1 (0.62) | CA2MAPK1SLC1A2SLC1A1SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1894994-B1 | Two or more phase face cleansing agent with improved reversible mixing and demixing solution | HENKEL AG & CO KGAA (DE) | 2013-10-16 | — | — | EP | claimed |
| EP-1894994-A1 | Two or more phase face cleansing agent with improved reversible mixing and demixing solution | Henkel KGaA (DE) | 2008-03-05 | — | — | EP | claimed |
| EP-1064914-B1 | Cosmetic composition for make-up removal and/or skin cleaning as a water-in-oil emulsion | OREAL (FR) | 2006-05-17 | — | — | EP | claimed |
| EP-0776655-B2 | Use of a polyholoside in a cleansing or make-up removing composition and composition containing it | OREAL (FR) | 2004-09-15 | — | — | EP | claimed |
| EP-1034774-B1 | Make-up remover or cleansing composition in the form of a water-in-oil emulsion | OREAL (FR) | 2002-05-15 | — | — | EP | claimed |
| EP-0995423-B1 | Cosmetic powder and its use as make-up remover or for skin and mucosa cleansing | OREAL (FR) | 2001-09-05 | — | — | EP | claimed |
| EP-0651990-B1 | Composition based on C12-C20 esters for make-up removal | OREAL (FR) | 1998-10-14 | — | — | EP | claimed |
| JP-58074756-A | — | — | None | — | — | JP | disclosed |
| US-20230047489-A1 | ANTIFOAM AND DEFOAMER PRODUCT | OLEON NV (BE) | 2023-02-16 | — | — | US | disclosed |
| EP-3842109-A1 | ANTIFOAM AND DEFOAMER PRODUCT | Oleon N.V. (BE) | 2021-06-30 | — | — | EP | disclosed |
| CN-106133027-A | Coating composition | PPG涂料欧洲有限责任公司 | 2016-11-16 | — | — | CN | disclosed |
| EP-2618903-B1 | PROCESS FOR RECOVERING AND RECYCLING AN ACID CATALYST | EASTMAN CHEM CO (US) | 2016-01-27 | — | — | EP | disclosed |
| EP-2831040-A1 | PROCESS FOR RECOVERING AND RECYCLING AN ACID CATALYST | Eastman Chemical Company (US) | 2015-02-04 | — | — | EP | disclosed |
| WO-2005054391-A2 | ADHESION-PROMOTING AGENT FOR A THERMAL INSULATION SURFACE | HEXION SPECIALTY CHEMICALS INC (US) | 2005-06-16 | — | — | WO | disclosed |
| EP-1355967-A1 | BLOCKED HDI-BASED POLYISOCYANATES | Bayer Aktiengesellschaft (DE) | 2003-10-29 | — | — | EP | disclosed |
| US-6515097-B2 | From hexamethylene diisocyante; for polyurethane plastics and coatings; crystallization resistance | BAYER AKTIENGESELLSCHAFT (DE) | 2003-02-04 | — | — | US | disclosed |
| US-20020151671-A1 | Blocked polyisocyanates based on HDI | BAYER AKTIENGESELLSCHAFT (DE) | 2002-10-17 | — | — | US | disclosed |
| WO-2002048230-A1 | BLOCKED HDI-BASED POLYISOCYANATES | BAYER AKTIENGESELLSCHAFT (DE) | 2002-06-20 | — | — | WO | disclosed |
| US-5686087-A | Cosmetic and/or pharmaceutical formulations with an improved feeling on the skin based on mixed guerbet alcohols | COGNIS IP MANAGEMENT GMBH (DE) | 1997-11-11 | — | — | US | disclosed |
| JP-S5874756-A | POLYVINYL FORMAL COATING | FUJIKURA LTD | 1983-05-06 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230047489-A1 | ANTIFOAM AND DEFOAMER PRODUCT | FABP1, FABP4, DAGLA | CA2 4114/4885MAPK1 4598/4885SLC1A2 4385/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.